Hepcinat Plus Tablet – Sofosbuvir 400mg + Daclatasvir 60mg Hepatitis C Combo

Hepcinat Plus (Sofosbuvir / Daclatasvir) is a prescription direct-acting antiviral (DAA) used to treat Chronic Hepatitis C Virus (HCV) infection. Modern DAA therapies like Hepcinat Plus deliver cure rates exceeding 95% in most HCV genotypes.
Composition: Sofosbuvir (400mg) + Daclatasvir (60mg)
Treatment Course: Typically 8–12 weeks.
Manufacturer: Natco Pharma Ltd
Prescription-only antiviral. Use under the supervision of a hepatologist or infectious disease specialist. Baseline genotyping and viral load testing required before starting treatment.